Life ScienceCompany
Bayer has acquired 20 companies, including 6 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 21 assets.
Bayer’s largest acquisition to date was in 2016, when it acquired Monsanto for $66.0B. It’s largest disclosed sale occurred in 2019, when it sold Bayer AG - Animal Health Business to Elanco Animal Health for $7.6B. Bayer has acquired in 7 different US states, and 7 countries. The Company’s most targeted sectors include life science (48%) and medical products (16%).
Join Mergr and gain access to Bayer’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity40
- M&A Buy Activity19
- M&A Sell Activity21
- Total Sectors Invested 7
- Total Countries Invested 7
- M&A Buy/Sell Connections 28
- M&A Advisors 13
Unlimited Searches
